Almond consumption and cardiovascular risk factors in adults with prediabetes

Journal of the American College of Nutrition

Volumn 29, Issue 3, 2010, Pages 189-197

  Wien, Michelle ^a   Bleich, David ^a   Raghuwanshi, Maya ^a   Gould Forgerite, Susan ^a   Gomes, Jacqueline ^a   Monahan Couch, Lynn ^b   Oda, Keiji ^c  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b WEST CHESTER UNIVERSITY   (United States)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALMOND; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; FEMALE; FOOD INTAKE; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MODEL; NUTRITIONAL COUNSELING; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; NUTS; PHYTOTHERAPY; PLANT PREPARATIONS; PREDIABETIC STATE; PRUNUS; RISK FACTORS;

PRUNUS DULCIS;

EID: 77957918023     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2010.10719833     Document Type: Article

References (30)

1. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, Geiss LS: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care 32:287–294, 2009.
2. Diabetes Prevention Program Research Group: The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med 24:137–144, 2007.
3. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KG: Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes in Mauritius? Diabetes Care 22:399–402, 1999.
4. American Diabetes Association: Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31:S61–S78, 2008.
5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403, 2002.
6. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544, 1997.
7. Fraser GE: Nut consumption, lipids, and risk of a coronary event. Clin Cardiol 22:11–15, 1999.
8. Hu FB, van Dam RM, Liu S: Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 44:805–817, 2001.
9. Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB: Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 288:2554–2560, 2002.
10. Beysen C, Karpe F, Fielding BA, Clark A, Levy JC, Frayn KN: Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia 45:1533–1541, 2002.
11. Paniagua JA, de la Sacristana AG, Sanchez E, Romero I, Vidal-Puig A, Berral FJ, Escribano A, Moyano MJ, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F: A MUFA-rich diet improves postprandial glucose, lipid and GLP-1 responses in insulinresistant subjects. J Am Coll Nutr 26:434–444, 2007.
12. Rocca AS, LaGreca J, Kalitsky J, Brubaker PL: Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 142:1148-1155, 2001.
13. Perfetti R, Brown TA, Velikina R, Busselen S: Control of glucose homeostasis by incretin hormones. Diabetes Technol Ther 1:297-305, 1999.
14. Wang P, Caspi L, Lam C, Chari M, Xiasosong L, Light P, Gutierrez-Juarez R, Ang M, Schwartz G, Lam T: Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 452:1012–1016, 2008.
15. Mansell PI, Macdonald IA: Reappraisal of the Weir equation for calculation of metabolic rate. Am J Physiol 258:1347–1354, 1990.
16. Wolever TM, Mehling C: Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance. Am J Clin Nutr 77:612-621, 2003.
17. Jebb SA, Prentice AM, Goldberg GR, Murgatroyd PR, Black AE, Coward WA: Changes in macronutrient balance during over-and underfeeding assessed by 12-d continuous whole-body calorimetry. Am J Clin Nutr 64:259–266, 1996.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419, 1985.
19. Wallace TM, Levy JC, Matthews DR: An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study. Diabet Med 21:568–576, 2004.
20. Wien MA, Sabate JM, Ikle DN, Cole SE, Kandeel FR: Almonds vs complex carbohydrates in a weight reduction program. Int J Obes Relat Metab Disord 27:1365–1372, 2003.
21. Jenkins DJ, Kendall CW, Marchie A, Josse AR, Nguyen TH, Faulkner DA, Lapsley KG, Singer W: Effect of almonds on insulin secretion and insulin resistance in nondiabetic hyperlipidemic subjects: a randomized controlled crossover trial. Metabolism 57:882–887, 2008.
22. Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77:1146–1155, 2003.
23. Phung OJ, Makanji SS, White CM, Coleman CI: Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J Am Diet Assoc 109:865–873, 2009.
24. Brunham LR, Kruit JK, Pape TD, Timmins JM, Reuwer AQ, Vasanji Z, Marsh BJ, Rodrigues B, Johnson JD, Parks JS, Verchere CB, Hayden MR: Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 13:340–347, 2007.
25. Jenkins DJA, Kendall CWC, Marchie A, Parker TL, Connelly PW, Qian W, Haight JS, Faulkner D, Vidgen E, Lapsley KG, Spiller GA: Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide. Circulation 106:1327–1332, 2002.
26. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE: Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294:326–333, 2005.
27. Sabaté J, Oda K, Ros E: Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med 170:821-827, 2010.
28. Jenkins DJ, Kendall CW, Marchie A, Josse AR, Nguyen TH, Faulkner DA, Lapsley KG, Blumberg J: Almonds reduce biomarkers of lipid peroxidation in older hyperlipidemic subjects. J Nutr 138:908–913, 2008.
29. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR: Effects of longterm vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338–1347, 2005.
30. Chesney CM, Elam MB, Herd JA, Davis KB, Garg R, Hunninghake D, Kennedy JW, Applegate WB: Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT). Am Heart J 140:631–636, 2000.